The Addition of Romidepsin to CHOEP and High-Dose Chemotherapy Plus Stem Cell Transplantation Did Not Ameliorate the Outcome of Untreated Angioimmunoblastic T-Cell or Follicular T-Helper Lymphoma: Subgroup Analysis of Phase II FIL-PTCL13 Study

Bibliographic Details
Title:	The Addition of Romidepsin to CHOEP and High-Dose Chemotherapy Plus Stem Cell Transplantation Did Not Ameliorate the Outcome of Untreated Angioimmunoblastic T-Cell or Follicular T-Helper Lymphoma: Subgroup Analysis of Phase II FIL-PTCL13 Study
Authors:	Chiappella, Annalisa, Dodero, Anna ^, Evangelista, Andrea ^, Re, Alessandro ^, Orsucci, Lorella ^, Usai, Sara Veronica ^, Castellino, Claudia ^, Stefoni, Vittorio ^, Pinto, Antonio ^, Zanni, Manuela ^, Ciancia, Rosanna ^, Ghiggi, Chiara ^, Rossi, Francesca Gaia ^, Arcari, Annalisa ^, Ilariucci, Fiorella ^, Zilioli, Vittorio Ruggero ^, Flenghi, Leonardo ^, Celli, Melania ^, Volpetti, Stefano ^, Benedetti, Fabio ^, Ballerini, Filippo ^, Musuraca, Gerardo ^, Bruna, Riccardo ^, Patti, Caterina ^, Leonardi, Francesco ^, Arcaini, Luca ^, Magagnoli, Massimo ^, Cavallo, Federica ^, Tabanelli, Valentina ^, Ciccone, Giovannino ^*, Pileri, Stefano A, Corradini, Paolo
Source:	In Blood 15 November 2022 140 Supplement 1:6538-6539
Database:	ScienceDirect